GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

PMID:16699171

From GONUTS
Jump to: navigation, search
Citation

Obreztchikova, M, Elouardighi, H, Ho, M, Wilson, BA, Gertsberg, Z and Steinberg, SF (2006) Distinct signaling functions for Shc isoforms in the heart. J. Biol. Chem. 281:20197-204

Abstract

Thrombin activates protease-activated receptor-1 (PAR-1) and engages signaling pathways that influence the growth and survival of cardiomyocytes as well as extracellular matrix remodeling by cardiac fibroblasts. This study examines the role of Shc proteins in PAR-1-dependent signaling pathways that influence ventricular remodeling. We show that thrombin increases p46Shc/p52Shc phosphorylation at Tyr(239)/Tyr(240) and Tyr(317) (and p66Shc-Ser(36) phosphorylation) via a pertussis toxin-insensitive epidermal growth factor receptor (EGFR) transactivation pathway in cardiac fibroblasts; p66Shc-Ser(36) phosphorylation is via a MEK-dependent mechanism. In contrast, cardiac fibroblasts express beta(2)-adrenergic receptors that activate ERK through a pertussis toxin-sensitive EGFR transactivation pathway that does not involve Shc isoforms or lead to p66Shc-Ser(36) phosphorylation. In cardiomyocytes, thrombin triggers MEK-dependent p66Shc-Ser(36) phosphorylation, but this is not via EGFR transactivation (or associated with Shc-Tyr(239)/Tyr(240) and/or Tyr(317) phosphorylation). Importantly, p66Shc protein expression is detected in neonatal, but not adult, cardiomyocytes; p66Shc expression is induced (via a mechanism that requires protein kinase C and MEK activity) by Pasteurella multocida toxin, a Galpha(q) agonist that promotes cardiomyocyte hypertrophy. These results identify novel regulation of individual Shc isoforms in receptor-dependent pathways leading to cardiac hypertrophy and the transition to heart failure. The observations that p66Shc expression is induced by a Galpha(q) agonist and that PAR-1 activation leads to p66Shc-Ser(36) phosphorylation identifies p66Shc as a novel candidate hypertrophy-induced mediator of cardiomyocyte apoptosis and heart failure.

Links

PubMed PMC1761690 Online version:10.1074/jbc.M601859200

Keywords

Adaptor Proteins, Signal Transducing/physiology; Animals; Animals, Newborn; Cell Division; Cells, Cultured; Fibroblasts/cytology; Heart/growth & development; Heart/physiology; Muscle Cells/cytology; Myocardium/cytology; Phosphorylation; Phosphoserine/metabolism; Protein Isoforms/physiology; Rats; Rats, Wistar; Receptor, Epidermal Growth Factor/genetics; Receptor, Epidermal Growth Factor/physiology; Shc Signaling Adaptor Proteins; Thrombin/pharmacology; Transcriptional Activation

Significance

Annotations

Gene product Qualifier GO Term Evidence Code with/from Aspect Extension Notes Status

RAT:SHC1

involved_in

GO:0014070: response to organic cyclic compound

ECO:0000270: expression pattern evidence used in manual assertion

P

Seeded From UniProt

complete

RAT:SHC1

involved_in

GO:0009636: response to toxic substance

ECO:0000270: expression pattern evidence used in manual assertion

P

Seeded From UniProt

complete

RAT:SHC1

involved_in

GO:0042542: response to hydrogen peroxide

ECO:0000270: expression pattern evidence used in manual assertion

P

Seeded From UniProt

complete


See also

References

See Help:References for how to manage references in GONUTS.